Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Cheng Sohanya Roshan sold 324 Karyopharm Therapeutics Inc. shares (Form 4)

Traded May 13 to May 14, 2026 · Filed May 15, 2026

From May 13 to May 14, 2026, Cheng Sohanya Roshan (EVP & Chief Commercial Officer) sold 324 Karyopharm Therapeutics Inc. shares at US$9.50 for US$3,078, leaving 107,940 shares. Filed May 15, 2026 (Form 4).

Sold
324 shares
Price
US$9.50
Value
US$3,078
Holding after
107,940 shares
Trading plan
No
Role
EVP & Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockAward947108,264Direct
May 14, 2026Common StockSale324US$9.50107,940Direct

Source

View original at SEC

Related